Here's a roundup of the latest coronavirus-related news.
As the United States nears the 200 million mark for the total number of COVID-19 vaccine doses administered, with 23.5% of Americans fully vaccinated against the virus as of April 15, coronavirus-related news is not slowing down.
Here’s a roundup of the latest coronavirus-related news, including a recent survey from the National Community Pharmacists Assocation (NCPA) and the CDC recommendation to temporarily pause the Johnson & Johnson vaccine.
NCPA: Independent Pharmacies Can Improve Vaccine Uptake in Vulnerable Communities
According to a new survey from the National Community Pharmacists Association (NCPA), independent community pharmacists are key to vaccinating socially vulnerable populations, including minority populations, but many are receiving inadequate vaccine supply.
Guillain-Barré Syndrome in COVID-19 Vaccine Trial Does Not Imply Causality, Experts Say
In a COVID-19 vaccine trial, an individual who received the vaccine subsequently developed Guillain-Barré syndrome; however, authors of a recently published paper are cautioning that this does not prove that the vaccine was the cause.
FDA, CDC Recommend Temporary Pause for Johnson & Johnson COVID-19 Vaccine
US health officials are recommending a pause in the administration of the single-dose Johnson & Johnson COVID-19 vaccine following 6 reports of a rare and severe type of blood clot, according to a joint statement issued on Tuesday by the CDC and FDA.
Study: Some Individuals Report Long-Term Effects Following Mild COVID-19
Although it is known that many patients hospitalized with COVID-19 report persistent long-term symptoms, there is not much knowledge regarding long-term outcomes among individuals with mild COVID-19.
What Contributes to Severe COVID-19 in Kids
COVID-19 may be mild in most cases for children, but severe cases do happen. An investigation offers insight into what factors may contribute to those cases.
How Does Digital Data Help Improve QOL in Patients With Long COVID and Autoimmune Diseases?
May 30th 2023Quality of life (QOL) for people living with autoimmune diseases benefits from an integrated approach that considers individual immune system sensitivities and patients’ life circumstances, a new study shows.
2 Clarke Drive
Cranbury, NJ 08512